GENE TO PATIENT

Serial Number 76131079
606

Registration Progress

Application Filed
Sep 19, 2000
Under Examination
Nov 13, 2001
Approved for Publication
Aug 1, 2001
Published for Opposition
Aug 21, 2001
Registered

Trademark Image

GENE TO PATIENT

Basic Information

Serial Number
76131079
Filing Date
September 19, 2000
Published for Opposition
August 21, 2001
Abandonment Date
November 14, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 14, 2003
Classes
042

Rights Holder

Millennium Pharmaceuticals, Inc.

03
Address
75 Sidney Street
Cambridge, MA 02138

Ownership History

Millennium Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Millennium Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Michael J. Bevilacqua

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Jan 12, 2004 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 7, 2003 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 8, 2003 EXT3 S SOU EXTENSION 3 FILED Loading...
May 7, 2003 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2002 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 6, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 6, 2002 EXT2 S SOU EXTENSION 2 FILED Loading...
May 29, 2002 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 13, 2002 MAIL I PAPER RECEIVED Loading...
May 13, 2002 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 13, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 21, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 1, 2001 NPUB O NOTICE OF PUBLICATION Loading...
May 4, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 7, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 042
research and consulting services and data analysis in the fields of genomics, diagnostics, pharmaceuticals, clinical trial design and biotechnology; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks; computer services, namely, creating and customizing databases for others in the field of life sciences; computer services, namely, custom software development; computer services, namely, software support and maintenance; computer services, namely contract computational services; consulting services, namely, research, development, validation and testing services for others in the fields of genomics, life sciences and pharmaceuticals medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services namely, identification and characterization of peptides and proteins for use in developing diagnostic and therapeutic products and services; research services, namely, identifying genes; drug screening using cultured microorganisms; chemical and genetic engineering of therapeutic molecules; pharmaceutical research and development services rendered to others; research services for discovering antibodies, antigens drugs, peptides, proteins, and gene therapy drugs; providing an online electronic database on global computer networks in the field of genomics, diagnostics, pharmacogenomics and biotechnology
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042